Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.

Autor: Mottola, D M, Brewster, W K, Cook, L L, Nichols, D E, Mailman, R B

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; July 1992, Vol. 262 Issue: 1 p383-393, 11p

ChemInform Abstract: Nonneurotoxic Tetralin and Indan Analogues of 3,4-(Methylenedioxy)amphetamine (MDA).

Autor: NICHOLS, D. E., BREWSTER, W. K., JOHNSON, M. P., OBERLENDER, R., RIGGS, R. M.

Publikováno v: ChemInform; Jun1990, Vol. 21 Issue 25, pno-no, 2p

Dihydrexidine: a new potent peripheral dopamine D~1 receptor agonist

Autor: Kohli, J. D., Horn, P. T., Glock, D., Brewster, W. K.

Publikováno v: European Journal of Pharmacology; 1993, Vol. 235 Issue: 1 p31-31, 1p

Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.

Autor: Knoerzer TA; Department of Medicinal Chemistry and Pharmacognosy, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907., Nichols DE, Brewster WK, Watts VJ, Mottola D, Mailman RB

Publikováno v: Journal of medicinal chemistry [J Med Chem] 1994 Jul 22; Vol. 37 (15), pp. 2453-60.

Assessment of the role of alpha-methylepinine in the neurotoxicity of MDMA.

Autor: Steele TD; Department of Pharmacology and Toxicology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, IN 47907., Brewster WK, Johnson MP, Nichols DE, Yim GK

Publikováno v: Pharmacology, biochemistry, and behavior [Pharmacol Biochem Behav] 1991 Feb; Vol. 38 (2), pp. 345-51.